Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain
Revista Española de Cardiología (English Edition) · 2025
DOI: 10.1016/j.rec.2024.12.012 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2025. Verfasst von Fernando de Frutos und 25 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Insuficiencia Cardiaca y Enfermedades Cardiacas Hereditarias, Departamento de Cardiología, Hospital Universitario de Bellvitge, L'Hospitale…. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Prealbumin, DNA, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Sociedad Espanola de Cardiologia.
Abstract (Originalsprache)
INTRODUCTION AND OBJECTIVES: In recent years, several cases of hereditary transthyretin amyloidosis (ATTRv) due to the p.Val142Ile variant have been described in patients without African ancestry. The aim of this study was to analyze the impact of ATTRv caused by p.Val142Ile in Spain, focusing on its phenotypic characteristics and its population frequency. METHODS: Patients diagnosed with ATTRv caused by p.Val142Ile, as well as carriers irrespective of their phenotype, were recruited from 16 centers in Spain. Baseline characteristics and events during follow-up were retrieved. Population frequency was assessed using data from the Spanish National DNA Bank (N=3569) and the Catalan Health Databank (N=790). RESULTS: The cohort included 164 participants: 75 probands (45.7%) and 89 relatives (54.3%). Among the probands, the mean age was 73.9±8.5 years, and 47 (62.7%) were male. Sixty-seven probands (89.3%) reported European ancestry, while only 6 (8%) reported African ancestry. Cardiac symptoms were the most frequent reason for ATTRv diagnosis (n=64; 85.3%). The median follow-up was 2.6 years [Interquartile range, 1.5-4.1]. Overall penetrance at ages 65, 75, and 85 years was 12.8%, 44.3%, and 94.2%, respectively. Tafamidis was initiated during follow-up in 38 patients: after 1 year of treatment, 14 patients (38.9%) met the combined endpoint (12 experienced disease progression and 2 died from cardiovascular causes). Population frequency was estimated to range between 0.0% and 0.12%, based on data from the Spanish and Catalan databases, respectively. CONCLUSIONS: ATTRv caused by p.Val142Ile has a significant prevalence in Spain. Its phenotypic features are characterized by late onset, male predominance, and cardiac involvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Insuficiencia Cardiaca y Enfermedades Cardiacas Hereditarias, Departamento de Cardiología, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Grupo Bioheart, Programa de Enfermed…
- Departamento de Cardiología, Hospital Universitario Puerta de Hierro-Majadahonda, Instituto Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), Madrid, Spain.
- Servicio de Cardiología, Complejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Gerencia Regional de Salud de Castilla y León (SACYL), Salamanca, Spain; Departamento…
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain; Unidad de Enfermedades Cardiacas Hereditarias, Servicio de Cardiología, Hospital Universitario Vall d'Hebron, Vall d'He…
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain; Unidad de Enfermedades Cardiacas Hereditarias, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Grupo de In…
- Enfermedades de las Neuronas Motoras, Unidad de Enfermedades Neuromusculares, Departamento de Neurología, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Universidad Autó…
Förderung
- Sociedad Espanola de Cardiologia
Zitieren
APA
de Frutos, F., Herrador, L., Peiró-Aventín, B., Eiros, R., Limeres Freire, J., Zorio, E., Carbayo, Á., Llongueras-Espí, P., García-Álvarez, A., Ripoll-Vera, T., Macías, R., Vilches, S., Ruiz-Bustillo, S., Arana-Achaga, X., Gayán Ordás, J., Piqueras-Flores, J., Ruiz-Cueto, M., Casasnovas, C., Tirón, C., …, & González-Costello, J. (2025). Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2024.12.012
Vancouver
de Frutos F, Herrador L, Peiró-Aventín B, Eiros R, Limeres Freire J, Zorio E, et al. Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain. Revista Española de Cardiología (English Edition). 2025. doi:10.1016/j.rec.2024.12.012
BibTeX
@article{deFrutos2025,
author = {de Frutos, Fernando and Herrador, Lorena and Peiró-Aventín, Belén and Eiros, Rocío and Limeres Freire, Javier and Zorio, Esther and Carbayo, Álvaro and Llongueras-Espí, Pasqual and García-Álvarez, Ana and Ripoll-Vera, Tomás and Macías, Rosa and Vilches, Silvia and Ruiz-Bustillo, Sonia and Arana-Achaga, Xabier and Gayán Ordás, Jara and Piqueras-Flores, Jesús and Ruiz-Cueto, María and Casasnovas, Carlos and Tirón, Coloma and Rojas-García, Ricard and Sevilla, Teresa and Rodríguez-Palomares, José Fernando and González-López, Esther and Villacorta, Eduardo and García-Pavía, Pablo and González-Costello, José},
title = {Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain},
journal = {Revista Española de Cardiología (English Edition)},
year = {2025},
doi = {10.1016/j.rec.2024.12.012}
}
EUVIMED